Abbott Laboratories (ABT) vs GE HealthCare Technologies Inc. (GEHC)
- Abbott Laboratories ABT 110.32 −2.89%
- GE HealthCare Technologies Inc. GEHC 82.70 −1.25%
Abbott Laboratories and GE HealthCare Technologies Inc. are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $37.9B — 5.2× the size. GE HealthCare Technologies Inc. trades at the lower P/E: 17.5× against 42.3×. Abbott Laboratories grew revenue faster over the last twelve months: 10.0% against 6.87%. GE HealthCare Technologies Inc. has the higher net margin (9.95% vs 9.75%) and the higher return on invested capital (8.86% vs 0.00%). Both pay a dividend; Abbott Laboratories yields more (2.22% vs 0.17%). Across the 23 metrics below, GE HealthCare Technologies Inc. leads on 14 and Abbott Laboratories on 9.
Valuation
Profitability
| Metric | ABT | GEHC | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.94% | 39.95% | 57.76% |
| Operating margin | 13.78% | 13.34% | (15.07%) |
| Net margin | 9.75% | 9.95% | (14.45%) |
| Free cash flow margin | 0.00% | 8.73% | (3.88%) |
| Return on equity | 0.00% | 19.89% | (10.35%) |
| Return on assets | 0.00% | 5.78% | (17.26%) |
| Return on invested capital | 0.00% | 8.86% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack